AMERIPRISE FINANCIAL INC

Position in ANNX — Annexon, Inc.

CIK 820027 MINNEAPOLIS, MN

Position in ANNX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$19,108,129

-$2,722,756 QoQ

Shares Held

3,449,121

-20.7% QoQ

Ownership

1.73%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

9 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 97.89036105140991.ToString("F0")% None 2.10963894859009.ToString("F0")%

Healthcare · as of Mar 31, 2026

AMERIPRISE FINANCIAL INC holds $4,230,069,783 across 189 Biotechnology names. ANNX ranks #29 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,633,481	$1,175,954,602
2	INSM	INSMED Inc	3,057,718	$499,998,043
3	JAZZ	Jazz Pharmaceuticals plc	1,608,476	$304,082,386
4	REGN	Regeneron Pharmaceuticals, Inc.	319,677	$246,995,233
5	ARGX	Argenx SE	215,910	$157,668,275
6	RVMD	Revolution Medicines, Inc.	1,579,793	$153,634,868
7	ASND	Ascendis Pharma A/S	476,466	$108,982,067
8	BBIO	BridgeBio Pharma, Inc.	1,248,521	$92,715,166

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$19,108,129	3,449,121	-20.7%	Shares	Defined	2026-05-15
2025-12-31	$21,830,885	4,348,782	+98.4%	Shares	Defined	2026-02-17
2025-09-30	$6,686,679	2,192,354	+1.2%	Shares	Defined	2025-11-14
2025-06-30	$5,198,827	2,166,178	-45.6%	Shares	Defined	2025-08-14
2025-03-31	$7,691,619	3,985,295	+330.1%	Shares	Defined	2025-05-14
2024-12-31	$4,753,672	926,642	+483.6%	Shares	Defined	2025-02-14
2024-09-30	$939,935	158,773	-35.7%	Shares	Defined	2024-11-14
2020-12-31	$6,184,187	247,071	+23.2%	Shares	Defined	2021-02-12
2020-09-30	$6,063,563	200,581	—	Shares	Defined	2020-11-16
No filing history on record for this holder in this stock.